None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects willing and able to provide signed informed consent prior to any study related to procedure. 2. Subjects of either sex in the age group between 18 to 50 years both inclusive. 3. Subjects suffering from hair loss of various severities. 4. iv. Subjects who committed not to use any other medicated / non-medicated shampoos/soaps (including soaps containing antibacterial/antifungal agents) or any other antidandruff treatment / hair products (including prescription and non-prescription medications such as oil, conditioner) for the entire duration of the study.
Exclusion criteria
Exclusion criteria: 1. History of systemic of cutaneous malignancy. 2. Nevi or cutaneous lesions currently. 3. Advanced or poorly controlled diabetes. 4. Subjects with known hypersensitivity to ingredients of the trial drug. 5. Subjects who underwent hair procedures within the past 2 weeks. 6. Subjects with H/o Myocardial infarction within 4 weeks prior to enrolment. 7. Subjects with immediate life-threatening diseases such as pre-existing cardiovascular, liver or neoplastic disease. 8. Subjects undergoing treatment for immunocompromised conditions/ psychiatric illness. 9. Subjects with history of alcohol or drug abuse. 10. Subjects participating in any other clinical trial. 11. Pregnant or lactating females.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of this study was to evaluate the efficacy of Mayukhi Herbal Hair Oil in enhancing hair growth and hair density in healthy subjects.Timepoint: Changes in Hair density (number of hair/cm2) will be assessed on baseline(visit 1), day-30 (visit 2), and on day-45 (visit 3) as follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| The study aims to evaluate the effect of the trial drug in Scalp Health of the subjects.Timepoint: Scalp Health Parameters: Dandruff, Itchiness, Oiliness (Seborrhea), Dryness and Scalp Irritation or Sensitivity will be assessed on baseline(visit 1), day-30 (visit 2), and on day-45 (visit 3) as follow-up | — |
Countries
India
Contacts
Pankajakasthuri Ayurveda Medical college and PG centre